High-dose sequential chemotherapy in refractory Hodgkin's and non-Hodgkin's lymphoma.

被引：0
|
作者：
Oyan, B [1 ]
Koc, Y [1 ]
Kansu, E [1 ]
机构：
[1] Inst Oncol, HSCT Unit, Ankara, Turkey
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5462
引用
收藏
页码：471B / 471B
页数：1
相关论文
共 50 条
  • [31] Interleukin 10 promoter polymorphisms in Hodgkin's and non-Hodgkin's lymphoma.
    Cunningham, LM
    Dunstan, R
    Joske, DJ
    Rule, S
    BLOOD, 1999, 94 (10) : 244B - 244B
  • [32] The leukemic phase of non-Hodgkin's lymphoma.
    Kim, JY
    Park, CJ
    Chi, HS
    Choi, SJ
    Huh, JR
    Kang, YK
    Suh, CW
    Kim, SB
    BLOOD, 2001, 98 (11) : 230B - 230B
  • [33] Intensified, sort duration chemotherapy of pediatric non-Hodgkin's lymphoma.
    Mukhopadhyay, A
    Saha, K
    Kundu, B
    Barman, B
    Sarkar, R
    Jana, S
    Gupta, PR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 815S - 815S
  • [34] Sequential high-dose chemotherapy plus autograft in refractory Hodgkin's disease patients
    Karanfilski, O
    Stojanovic, A
    Cevreska, L
    Pivkova, A
    Stojanoski, Z
    Trajkova, S
    Krstevska-Balkanov, S
    Georgievski, B
    BONE MARROW TRANSPLANTATION, 2005, 35 : S386 - S387
  • [35] High-dose sequential (RDS) chemotherapy with high-dose ARA-C and Rituximab prolongs the survival of patients with resistant/relapsed B-cell non-Hodgkin's lymphoma.
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Bellavita, P
    Motta, T
    Barbui, T
    BLOOD, 2002, 100 (11) : 646A - 646A
  • [36] Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma
    Johnston, LJ
    Stockerl-Goldstein, KE
    Hu, WW
    Negrin, RS
    Hoppe, RT
    Blume, KG
    Horning, SJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (5A) : 555 - 562
  • [37] High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    BLOOD, 2004, 104 (11) : 393B - 393B
  • [38] The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
    Beard S.M.
    Lorigan P.C.
    Sampson F.C.
    British Journal of Cancer, 2000, 82 (1) : 81 - 84
  • [39] Sequential Hodgkin's and non-Hodgkin's lymphoma in non-immunocompromised patients
    Khristi, J.
    Mey, U.
    Kirfel, J.
    Schmidt-Wolf, I. G. H.
    Guetgemann, I.
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1565 - 1567
  • [40] Hodgkin's and Non-Hodgkin's Lymphoma
    Manning, Jaye
    CANCER FORUM, 2007, 31 (02) : 117 - 117
12345